Search results
Results from the WOW.Com Content Network
Androgen replacement therapy formulations and dosages used in women Route Medication Major brand names Form Dosage Oral: Testosterone undecanoate: Andriol, Jatenzo: Capsule: 40–80 mg 1x/1–2 days Methyltestosterone: Metandren, Estratest: Tablet: 0.5–10 mg/day Fluoxymesterone: Halotestin: Tablet: 1–2.5 mg 1x/1–2 days Normethandrone a ...
50–100 mg 1x/3–6 months Notes: Premenopausal women produce about 230 ± 70 μg testosterone per day (6.4 ± 2.0 mg testosterone per 4 weeks), with a range of 130 to 330 μg per day (3.6–9.2 mg per 4 weeks). Footnotes: a = Mostly discontinued or unavailable. b = Over-the-counter. Sources: See template.
Cyproterone acetate (CPA), sold alone under the brand name Androcur or with ethinylestradiol under the brand names Diane or Diane-35 among others, is an antiandrogen and progestin medication used in the treatment of androgen-dependent conditions such as acne, excessive body hair growth, early puberty, and prostate cancer, as a component of feminizing hormone therapy for transgender individuals ...
2.5–40 mg/day Depo-Provera: Progestogen: IM: 150 mg every 3 mos: Depo-SubQ Provera 104: Progestogen: SC: 104 mg every 3 mos Hydroxyprogesterone caproate: Proluton: Progestogen: IM: 250 mg/wk Dydrogesterone: Duphaston: Progestogen: Oral: 20 mg/day Drospirenone: Slynd: Progestogen: Oral: 3 mg/day Domperidone [d] Motilium: Prolactin releaser ...
In comparison with the smaller dose, finasteride 5mg had a few additional prominent side effects, and a slightly higher severity of the side effects seen in the 1mg dose.
Mesterolone, also known as 1α-methyl-4,5α-dihydrotestosterone (1α-methyl-DHT) or as 1α-methyl-5α-androstan-17β-ol-3-one, is a synthetic androstane steroid and derivative of DHT. [ 19 ] [ 20 ] [ 2 ] It is specifically DHT with a methyl group at the C1α position.
Methyltestosterone, sold under the brand names Android, Metandren, and Testred among others, is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, at low doses as a component of menopausal hormone therapy for menopausal symptoms like hot flashes, osteoporosis, and low sexual desire in women, and to treat ...
The rates of gynecomastia with leuprorelin have been found to range from 3 to 16%. [27] A cohort of women that were prescribed leuprorelin to delay precocious puberty as children has developed osteoporosis and brittle teeth at an unexpected rate; However, the FDA has not established that these conditions were caused by leuprorelin. [28]